◇◇新语丝(www.xys.org)(xys6.dxiong.com)(www.xinyusi.info)(xys2.dropin.org)◇◇

举报一个用已经因为学术不端被取消了博士学位在国内招摇撞骗的恶劣情况

　　作者：CSU的一个校友

　　方先生：

　　你好!

　　特向您举报一个用已经因为学术不端被取消了的博士学位在国内招摇撞骗的
恶劣情况：

　　中国留学生金威于1998年从北京大学化学系硕士毕业到美国科罗拉多州立大
学化学系读博士学位，于2004年毕业。毕业后导师发现他的实验无法重复，启动
正式调查以后，证明他伪造实验数据。他的博士论文因此被取消，并上报NIH。
此情况可见NIH网站上的报道：

　　http://grants.nih.gov/grants/guide/notice-files/NOT-OD-07-067.html

　　Wei Jin, Colorado State University: Based on an investigation 
conducted by Colorado State University (CSU) and additional analysis 
and information obtained by the Office of Research Integrity during 
its oversight review, the U.S. Public Health Service (PHS) found that 
Mr. Wei Jin, former doctoral candidate, Department of Chemistry, CSU, 
engaged in research misconduct in research funded by National Cancer 
Institutes (NCI), National Institutes of Health (NIH), grant R01 
CA85419. Specifically, Mr. Jin falsified data/results by claiming he 
had performed a novel total synthesis of renieramycin G, when in fact, 
he obtained renieramycin G through a relatively simple reaction 
sequence from renieramycin M, a natural product that was a gift to the 
laboratory and that had been isolated by others from the Thai sponge. 
Mr. Jin included the falsified data/results in:

　　His research notebooks and other records of his research; His 
dissertation, ``Asymmetric total synthesis of (-)-Reineramycin G and 
studies toward the total synthesis of Ecteinascidin-743';

　　A manuscript, Jin, W. & Williams, R., ``Asymmetric total synthesis 
of (-)-Renieramycin G,' accepted by the Journal of the American 
Chemical Society; and

　　Supplemental information relative to the manuscript to be 
published online. 

　　ORI has implemented the following administrative actions for a 
period of three (3) years, beginning on May 8, 2007: (1) Mr. Jin is 
debarred from eligibility for any contracting or subcontracting with 
any agency of the United States Government and from eligibility or 
involvement in nonprocurement programs of the United States Government 
referred to as ``covered transactions' as defined in HHS' 
implementation of OMB Guidelines to Agencies on Government-wide 
Debarment and Suspension at 2 CFR Part 376, et seq.; and (2) Mr. Jin 
is prohibited from serving in any advisory capacity to PHS, including 
but not limited to service on any PHS advisory committee, board, 
and/or peer review committee, or as a consultant. 

　　NIH对金威的学术造假行为进行查处之后，他回到中国，继续声称自己是科
罗拉多州立大学的博士，招摇撞骗。如下面这个他开的公司的网页上，继续声称
自己是科罗拉多大学的有机化学博士：

　　http://www.adobechem.cn/about-seniormanagement.html

　　Wei Jin, Ph.D., Chief Operating Officer
　　2008-2011: Director, ShangPharma / ChemExplorer, China
　　2006-2008, Associate Director, ShangPharma / ChemPartner, China
　　2004-2006: Postdoc, Scripps Research Institute, USA
　　Ph.D. in Organic Chemistry, Colorado State University, USA, 2004

　　希望您能揭露这样的已经有确凿学术不端历史的人继续在国内行骗，利用国
人对美国学位的盲目崇拜获取利益。

(XYS20111206)

◇◇新语丝(www.xys.org)(xys6.dxiong.com)(www.xinyusi.info)(xys2.dropin.org)◇◇